Citigroup
IMA

Citigroup’s ImageneBio Inc IMA Stock Holding History

Citigroup’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Buy
+224
New +$1.45K ﹤0.01% 5472
2024
Q3 		– Sell
-417
Closed -$8.26K – 5731
2024
Q2 		$8.26K Sell
417
-67
-14% -$1.18K ﹤0.01% 5188
2024
Q1 		$8.24K Buy
484
+98
+25% +$1.78K ﹤0.01% 5243
2023
Q4 		$9.12K Buy
386
+385
+38,500% +$12.6K ﹤0.01% 5213
2023
Q3 		$43 Sell
1
-527
-100% -$31.7K ﹤0.01% 5537
2023
Q2 		$41.5K Buy
528
+169
+47% +$12.1K ﹤0.01% 4736
2023
Q1 		$14.8K Buy
359
+301
+519% +$13.8K ﹤0.01% 4603
2022
Q4 		$1.86K Buy
58
+1
+2% +$32 ﹤0.01% 5258
2022
Q3 		$2K Sell
57
-21
-27% -$1.21K ﹤0.01% 5502
2022
Q2 		$4K Sell
78
-209
-73% -$11.5K ﹤0.01% 5686
2022
Q1 		$21K Sell
287
-468
-62% -$49.8K ﹤0.01% 5114
2021
Q4 		$114K Buy
755
+641
+562% +$104K ﹤0.01% 4662
2021
Q3 		$17K Buy
114
+78
+217% +$11.3K ﹤0.01% 5289
2021
Q2 		$6K Buy
+36
New +$7.94K ﹤0.01% 5806

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup's IMA Position: Q1 2026 in Review

Citigroup opened a new position in ImageneBio Inc (IMA) in Q1 2026: 224 shares worth $1.12K. The stake represents ﹤0.01% of the portfolio and ranks #5472 among its holdings. This is a return to the name: Citigroup previously reported a position in IMA as recently as Q2 2024.

Citigroup first reported a position in IMA in Q2 2021 and has held it in 14 quarters since. The position peaked at $114K in Q4 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Citigroup held 224 shares of ImageneBio Inc worth $1.12K as of Q1 2026.
  • ImageneBio Inc was a new Citigroup position in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5472 holding.
  • Citigroup first reported a position in ImageneBio Inc in Q2 2021 and has held it in 14 quarters since.
  • Citigroup's ImageneBio Inc position peaked at $114K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.